Sysmex Corp
Company Profile
Business description
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.
Contact
1-5-1 Wakinohara-Kaigandori
Chuo-ku, Hyogo Prefecture
Kobe6510073
JPNT: +81 782650500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 March 2026
Employees
10,940
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,021.90 | 60.20 | 0.76% |
CAC 40 | 7,285.86 | 44.11 | -0.60% |
DAX 40 | 21,205.86 | 105.16 | -0.49% |
Dow JONES (US) | 39,142.23 | 527.16 | -1.33% |
FTSE 100 | 8,275.66 | 0.06 | 0.00% |
HKSE | 21,395.14 | 338.16 | 1.61% |
NASDAQ | 16,286.45 | 20.71 | -0.13% |
Nikkei 225 | 34,730.28 | 352.68 | 1.03% |
NZX 50 Index | 12,118.99 | 51.07 | 0.42% |
S&P 500 | 5,282.70 | 7.00 | 0.13% |
S&P/ASX 200 | 7,819.10 | 60.20 | 0.78% |
SSE Composite Index | 3,280.34 | 4.34 | 0.13% |